Opportunistic Infections Citation List:
June 25 - July 8, 2010
OPPORTUNISTIC PROTOZOA COMPOUNDS (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])
1. Antifungal and Cytotoxic Activity of Withanolides from Acnistus arborescens. Roumy, V., M. Biabiany, T. Hennebelle, E.M. Aliouat, M. Pottier, H. Joseph, S. Joha, B. Quesnel, R. Alkhatib, S. Sahpaz, and F. Bailleul. J Nat Prod. [Epub ahead of print]; PMID[20590148].
[Pubmed]. OI_0625-070810.
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
2. In vitro activity of anidulafungin and other agents against esophageal candidiasis-associated isolates from a phase 3 clinical trial. Pfaller, M.A., R. Hollis, B.P. Goldstein, S. Messer, D. Diekema, and T. Henkel. J Clin Microbiol. 48(7): p. 2613-4; PMID[20504981].
[Pubmed]. OI_0625-070810.
3. Novel short antibacterial and antifungal peptides with low cytotoxicity: efficacy and action mechanisms. Qi, X., C. Zhou, P. Li, W. Xu, Y. Cao, H. Ling, W.N. Chen, C.M. Li, R. Xu, M. Lamrani, Y. Mu, S. Leong, M.W. Chang, and M.B. Chan-Park. Biochem Biophys Res Commun. [Epub ahead of print]; PMID[20603106].
[Pubmed]. OI_0625-070810.
4. In vitro antifungal activity of phenylheptatriyne from Bidens cernua L. against yeasts. Rybalchenko, N.P., V.A. Prykhodko, S.S. Nagorna, N.N. Volynets, A.N. Ostapchuk, V.V. Klochko, T.V. Rybalchenko, and L.V. Avdeeva. Fitoterapia. 81(5): p. 336-8; PMID[19837144].
[Pubmed]. OI_0625-070810.
5. Anticandidal Action of Fungal Chitosan against Candida albicans. Tayel, A.A., S. Moussa, W.F. El-Tras, D. Knittel, K. Opwis, and E. Schollmeyer. Int J Biol Macromol. [Epub ahead of print]; PMID[20603144].
[Pubmed]. OI_0625-070810.
6. Evaluation of in vitro activity of carvacrol against Candida albicans strains. Vardar-Unlu, G., A. Yagmuroglu, and M. Unlu. Nat Prod Res. 24(12): p. 1189-93; PMID[20582812].
[Pubmed]. OI_0625-070810.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
7. Bis dihydropyrimidine: synthesis and antimycobacterial activity. Ali, M.A., E. Manogaran, J. Govindasamy, V. Sellappan, and S. Pandian. J Enzyme Inhib Med Chem. [Epub ahead of print]; PMID[20583864].
[Pubmed]. OI_0625-070810.
8. Antitubercular Resorcinol Analogs and Benzenoid C-Glucoside from the Roots of Ardisia cornudentata. Chang, C.P., H.S. Chang, C.F. Peng, S.J. Lee, and I.S. Chen. Planta Med. [Epub ahead of print]; PMID[20607650].
[Pubmed]. OI_0625-070810.
9. New drugs and regimens for treatment of TB. Leibert, E. and W.N. Rom. Expert Rev Anti Infect Ther. 8(7): p. 801-13; PMID[20586565].
[Pubmed]. OI_0625-070810.
10. A note to the biological activity of benzoxazine derivatives containing the thioxo group. Waisser, K., E. Petrlikova, M. Perina, V. Klimesova, J. Kunes, K. Palat, Jr., J. Kaustova, H.M. Dahse, and U. Mollmann. Eur J Med Chem. 45(7): p. 2719-25; PMID[20226572].
[Pubmed]. OI_0625-070810.
Citations from the ISI Web of Knowledge Listings for O.I.
11. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria. Carroll, J., L.A. Draper, P.M. O'Connor, A. Coffey, C. Hill, R.P. Ross, P.D. Cotter, and J. O'Mahony. International Journal of Antimicrobial Agents. 36(2): p. 132-136; ISI[000278870300008].
[WOS]. OI_0625-070810.
12. Triazole-Linked Inhibitors of Inosine Monophosphate Dehydrogenase from Human and Mycobacterium tuberculosis. Chen, L.Q., D.J. Wilson, Y.L. Xu, C.C. Aldrich, K. Felczak, Y.Y. Sham, and K.W. Pankiewicz. Journal of Medicinal Chemistry. 53(12): p. 4768-4778; ISI[000278805500017].
[WOS]. OI_0625-070810.
13. Antitubercular Potential of Plants: A Brief Account of Some Important Molecules. Negi, A.S., J.K. Kumar, S. Luqman, D. Saikia, and S.P.S. Khanuja. Medicinal Research Reviews. 30(4): p. 603-645; ISI[000278760700002].
[WOS]. OI_0625-070810.
14. Synthesis and antimicrobial activity of [N-1-(N-substituted-arylidene-hydrazino)-acetyl]-2-methyl-imidazoles and [N-1-(4-substituted-aryl-3-chloro-2-oxo-1-azetidinyl-amino)-acetyl]-2-me thyl-imidazoles. Srivastava, S.K., R. Dua, and S.D. Srivastava. Proceedings of the National Academy of Sciences India Section a-Physical Sciences. 80A(I Web of Knowledge Search Alert): p. 117-121; ISI[000278891700003].
[WOS]. OI_0625-070810.
15. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of Antimycobacterium tuberculosis agents. Bacelar, A.H., M.A. Carvalho, and M.F. Proenca. European Journal of Medicinal Chemistry. 45(7): p. 3234-3239; ISI[000278626400069].
[WOS]. OI_0625-070810.
16. Novel 2-Hydrazino-pyrimidin-4(3H)-One Derivatives as Potential Dihydrofolate Reductase Inhibitors. Degani, M.S., S. Bag, R. Bairwa, N.R. Tawari, and S.F. Queener. Journal of Heterocyclic Chemistry. 47(3): p. 558-563; ISI[000278638500013].
[WOS]. OI_0625-070810.
17. Preparation and Properties In Vitro and In Vivo of Antitubercular Pyrroles. Hearn, M.J., M.F. Chen, M.S. Terrot, E.R. Webster, and M.H. Cynamon. Journal of Heterocyclic Chemistry. 47(3): p. 707-712; ISI[000278638500035].
[WOS]. OI_0625-070810.